Global Quantitative Pathology Imaging Market is forecasted to be appraised at US$ 9.5 Billion by 2032

Quantitative Pathology Imaging Market
Quantitative Pathology Imaging Market

The global quantitative pathology imaging market is on the brink of unprecedented growth, with projections indicating a staggering valuation of US$ 9.5 Billion by 2032, a substantial leap from the recorded US$ 2.77 Billion in 2022. This remarkable surge is fueled by a robust Compound Annual Growth Rate (CAGR) of 11.9% anticipated during the forecast period.

The exponential expansion of the QPI market is primarily attributed to progressive advancements in quantitative pathology imaging technologies. These cutting-edge technologies are reshaping the landscape of pathology, offering precise and detailed insights that significantly elevate diagnostic accuracy and inform treatment decisions.

Get Sample Copy of Latest Reports: https://www.futuremarketinsights.com/reports/sample/rep-gb-5041

A key driver of this growth is the advent of digital pathology, which involves the utilization of digital scanners to convert tissue samples into high-resolution digital images. These digital images can then be analyzed using QPI software to extract quantitative information. Digital pathology is gaining traction due to its numerous advantages over traditional microscopy, including enhanced image quality, seamless image sharing capabilities, and the ability to perform intricate quantitative analysis.

Furthermore, the escalating demand for personalized medicine is propelling the QPI market forward. Personalized medicine entails tailoring treatment strategies to individual patients based on their distinct genetic and molecular profiles. QPI plays a pivotal role in this paradigm shift by enabling the identification of biomarkers that guide personalized treatment decisions, thereby optimizing patient outcomes.

The key takeaways from the quantitative pathology imaging market report are as follows:

  • The global quantitative pathology imaging market is expected to grow at a CAGR of 11.9% during the forecast period.
  • The market is driven by the increasing prevalence of cancer and other chronic diseases, the rising demand for personalized medicine, and the growing adoption of digital pathology.
  • Oncology is the largest segment of the quantitative pathology imaging market, accounting for over 50% of the market share in 2022.
  • North America is the largest regional market for quantitative pathology imaging, accounting for over 40% of the global market share in 2022.

Methodology Details Just a Click Away: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5041

Key Companies Profiled:

  • Leica Biosystems (Danaher)
  • Hamamatsu Photonics, Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • Mikroscan Technologies
  • Inspirata, Inc.
  • 3DHISTECH Ltd.
  • Visiopharm A/S
  • Huron Technologies International, Inc.
  • ContextVision AB

Key Segments In The Quantitative Pathology Imaging Market:

By Product:

  • Instruments
  • Software
  • Services

By Application:

  • Drug Discovery and Development
  • Academic Research
  • Disease Diagnosis

By End-User:

  • Hospitals
  • Clinics
  • Pathology Diagnostic Laboratories
  • Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • Asia
  • Middle East and Africa

Get a Purchase on the Report: https://www.futuremarketinsights.com/checkout/5041

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these